selected publications
-
article
- Longterm safety, efficacy, and inhibition of structural damage progression over 5 years of treatment with abatacept in patients with rheumatoid arthritis in the abatacept in inadequate responders to methotrexate trial. Journal of Rheumatology. 41:1077-1087. 2014-01-01
- Abatacept in subjects who switch from intravenous to subcutaneous therapy: Results from the phase IIIb ATTUNE study. Annals of the Rheumatic Diseases. 71:857-861. 2012-01-01
- Long-term safety, efficacy and inhibition of radiographic progression with abatacept treatment in patients with rheumatoid arthritis and an inadequate response to methotrexate: 3-Year results from the AIM trial. Annals of the Rheumatic Diseases. 70:1826-1830. 2011-01-01
- Results of a two-year followup study of patients with rheumatoid arthritis who received a combination of abatacept and methotrexate. Arthritis and Rheumatism. 58:953-963. 2008-01-01
- Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: A randomized trial. Annals of Internal Medicine. 144:865-876. 2006-01-01